HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A Review

HE4 Tissue Expression as A Putative Prognostic Marker in Low-Risk/Low-Grade Endometrioid Endometrial Cancer: A Review

Low-grade stage I endometrioid endometrial carcinomas should have an excellent prognosis, but a small subset of these cancers can relapse. The search for putative immunohistochemical prognostic markers for relapse in low-risk/low-grade endometrioid endometrial cancers remains open. Among the candida...

Full description

Bibliographic Details
Main Authors:	Valerio Mais, Maria Luisa Fais, Michele Peiretti, Daniela Fanni, Elena Massa, Giulia Carboni, Giuseppina Fais, Giuseppe Deo, Stefano Angioni
Format:	Article
Language:	English
Published:	MDPI AG 2022-11-01
Series:	Current Oncology
Subjects:	endometrial cancer endometrial hyperplasia cancer genome atlas human epididymis protein 4 HE4 immunohistochemistry
Online Access:	https://www.mdpi.com/1718-7729/29/11/673

Similar Items

HE4 as a Biomarker for Endometrial Cancer
by: Roya Behrouzi, et al.
Published: (2021-09-01)

HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines
by: Sean Dowdy, et al.
Published: (2013-03-01)

HE4 in the Diagnostic Approach of Endometrial Cancer in Patients with Postmenopausal Bleeding, the METRODEC Protocol: Protocol for a Multicenter Prospective Study
by: Manon Degez, et al.
Published: (2021-07-01)

Rapid identification of endometrial hyperplasia and endometrial endometrioid cancer in young women
by: Dan Kuai, et al.
Published: (2023-07-01)

Assessment of levels of the tumor markers HE4 and CA125 considering staging, grading and histological types of endometrial cancer
by: Nabil Abdalla, et al.
Published: (2016-11-01)

Usefulness of HE4 protein in differentiation of pelvic masses in woman
by: Andrzej Brenk, et al.
Published: (2019-04-01)

The Utility of Serum HE4 in Predicting Myometrial Invasion in Patients with Endometrial Cancer
by: Malihe Hasanzadeh Mofrad, et al.
Published: (2020-10-01)

Urine CA125 and HE4 for the Triage of Symptomatic Women with Suspected Endometrial Cancer
by: Kelechi Njoku, et al.
Published: (2022-07-01)

The value of serum HE4 and CA125 levels for monitoring the recurrence and risk stratification of endometrial endometrioid carcinoma
by: Sainan Gong, et al.
Published: (2023-07-01)

Can the Determination of HE4 and CA125 Markers Affect the Treatment of Patients with Endometrial Cancer?
by: Aneta Cymbaluk-Płoska, et al.
Published: (2021-03-01)

Rate of premalignant and malignant endometrial lesion in “low-risk” premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy
by: Sangam Jha, et al.
Published: (2021-11-01)

The incidence rates of endometrial hyperplasia and endometrial cancer: a four-year population-based study
by: Jin-Sung Yuk
Published: (2016-08-01)

The present status of metformin in fertility-preserving treatment in atypical endometrial hyperplasia and endometrioid endometrial cancer
by: Jun Guan, et al.
Published: (2022-10-01)

Predictive Utility of Systemic Immune Inflammation Index (SII) in Identifying Endometrial Carcinoma in Premalignant Endometrial Lesions
by: Caner Köse, et al.
Published: (2023-10-01)

PTEN Immunoexpression in Atypical Endometrial Hyperplasia and Endometrioid Endometrial Carcinoma: A Research Protocol
by: Garima Akhil chandrakar, et al.
Published: (2023-07-01)

Baseline Serum HE4 But Not Tissue HE4 Expression Predicts Response to the Levonorgestrel-Releasing Intrauterine System in Atypical Hyperplasia and Early Stage Endometrial Cancer
by: Roya Behrouzi, et al.
Published: (2020-01-01)

Immunohistochemical expression of estrogen and progesterone receptors in endometrial hyperplasia and endometrioid carcinoma
by: Sarmadi S, et al.
Published: (2012-06-01)

Serum CA125 and HE4 as Biomarkers for the Detection of Endometrial Cancer and Associated High-Risk Features
by: Chloe E. Barr, et al.
Published: (2022-11-01)

Diagnostic and Prognostic Values of Serum EpCAM, TGM2, and HE4 Levels in Endometrial Cancer
by: Ting Lan, et al.
Published: (2020-09-01)

Endometrial hyperplasia and progesterone resistance: a complex relationship
by: Mekan R. Orazov, et al.
Published: (2023-03-01)

Gastric mucosa as a rare recurrence location of endometrial endometrioid adenocarcinoma
by: Kathleen Lundeberg, et al.
Published: (2024-06-01)

Concordance between the Hysteroscopic Diagnosis of Endometrial Hyperplasia and Histopathological Examination
by: Pasquale De Franciscis, et al.
Published: (2019-10-01)

Endometrial sampling in low-risk patients with abnormal uterine bleeding: a systematic review and meta-synthesis
by: Brenda F. Narice, et al.
Published: (2018-07-01)

Does Preoperative Diagnosis of Endometrial Hyperplasia Necessitate Intraoperative Frozen Section Consultation?
by: Gokhan Boyraz, et al.
Published: (2016-12-01)

Clinical factors of the risk of hyperplastic endometry processes on tamoxifen therapy with breast cancer: Retrospective population study
by: Ekaterina O. Golubenko, et al.
Published: (2023-05-01)

Combination of serum CST1 and HE4 for early diagnosis of endometrial cancer
by: Wenhui Zhong, et al.
Published: (2023-12-01)

Pathology findings among women with alterations in uterine bleeding patterns in cameroon
by: Simon M. Manga, et al.
Published: (2021-08-01)

Tao brush endometrial cytology is a sensitive diagnostic tool for cancer and hyperplasia among women presenting to clinic with abnormal uterine bleeding
by: Stephanie R. DeJong, et al.
Published: (2021-10-01)

miRNAs as Candidate Biomarker for the Accurate Detection of Atypical Endometrial Hyperplasia/Endometrial Intraepithelial Neoplasia
by: Simona Giglio, et al.
Published: (2019-06-01)

Spatial expression of the FGFR2b splice isoform and its prognostic significance in endometrioid endometrial carcinoma
by: Asmerom T Sengal, et al.
Published: (2022-11-01)

Utility of tumor marker HE4 and CA125 to predict staging in endometrioid adenocarcinoma of the uterus
by: Narges Zamani, et al.
Published: (2015-11-01)

Analysis of the Impact of Comorbidities on Endometrial Lesions Using the Charlson Comorbidity Index in Western Romania
by: Alexandru Furau, et al.
Published: (2021-09-01)

Endometrial markers of polycystic ovary syndrome (literature review)
by: E. M. Sharifulin, et al.
Published: (2017-09-01)

The Application of HE4 in Diagnosis of Gynecological Pelvic Malignant Tumor
by: Shuyi WANG, et al.
Published: (2009-02-01)

Risk of Pre-Malignancy or Malignancy in Postmenopausal Endometrial Polyps: A CHAID Decision Tree Analysis
by: Michael Wong, et al.
Published: (2021-06-01)

The retrospective analysis results of the endometrial tissue pathological conditions development
by: V. V. Artyomenko, et al.
Published: (2020-11-01)

Risk factors of endometrial cancer in patients with endometrial hyperplasia: implication for clinical treatments
by: Jie Zhao, et al.
Published: (2021-08-01)

The reproductive function of patients with prior atypical endometrial hyperplasia and endometrial cancer treatment: cohort study
by: Lana G. Dzhanashvili, et al.
Published: (2022-09-01)

Analysis of endometrial lavage microbiota reveals an increased relative abundance of the plastic-degrading bacteria Bacillus pseudofirmus and Stenotrophomonas rhizophila in women with endometrial cancer/endometrial hyperplasia
by: Angel Chao, et al.
Published: (2022-11-01)

The Diagnostic Role of FGF 21 in Endometrial Cancer and Other Pathologies of the Uterine Corpus
by: Anna Jagodzińska, et al.
Published: (2023-01-01)